0
0

Access to Birth Control Act

12/30/2022, 2:34 AM

Congressional Summary of S 3223

Access to Birth Control Act

This bill requires pharmacies to comply with certain rules related to ensuring access to contraceptives.

Specifically, pharmacies must provide without delay a customer with any contraceptive or related medication that is in stock. If the contraceptive is not in stock, the pharmacy must immediately inform the customer and either order the contraceptive or refer the customer to a pharmacy that has it in stock. Laws in some states provide pharmacists with the right to refuse to dispense contraceptive-related drugs on religious or conscience grounds.

Pharmacies may refuse to provide a contraceptive to a customer (1) if the customer lacks a valid prescription for a prescription contraceptive or is unable to pay for the contraceptive, or (2) based on a pharmacy employee's professional clinical judgment.

The bill also establishes a private cause of action and civil monetary penalties for violations of the bill.

Current Status of Bill S 3223

Bill S 3223 is currently in the status of Bill Introduced since November 17, 2021. Bill S 3223 was introduced during Congress 117 and was introduced to the Senate on November 17, 2021.  Bill S 3223's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of November 17, 2021

Bipartisan Support of Bill S 3223

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
21
Democrat Cosponsors
21
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 3223

Primary Policy Focus

Health

Potential Impact Areas

- Civil actions and liability
- Family planning and birth control
- Health care coverage and access
- Health technology, devices, supplies
- Women's health

Alternate Title(s) of Bill S 3223

Access to Birth Control Act
Access to Birth Control Act
A bill to establish certain duties for pharmacies to ensure provision of Food and Drug Administration-approved contraception, medication related to contraception, and for other purposes.

Comments